InMed Pharmaceuticals Inc. (MTRI) bonds
MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM
$15.61+3.41 (+27.94%)
Close on Nov 11, 2026Market cap $85.75MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
InMed Pharmaceuticals reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
Individual notes, bonds and loans
InMed Pharmaceuticals's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
See a number that looks wrong?